Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain

S Agarwal, R Sane, R Oberoi, JR Ohlfest… - Expert reviews in …, 2011 - cambridge.org
Glioblastoma multiforme, because of its invasive nature, can be considered a disease of the
entire brain. Despite recent advances in surgery, radiotherapy and chemotherapy, current …

Molecularly targeted therapy for malignant glioma

S Sathornsumetee, DA Reardon, A Desjardins… - Cancer, 2007 - Wiley Online Library
Malignant gliomas are relatively uncommon but lethal cancers. Despite recent research
efforts in cancer therapy, the prognosis of patients with malignant gliomas has remained …

Stem cell–like glioma cells promote tumor angiogenesis through vascular endothelial growth factor

S Bao, Q Wu, S Sathornsumetee, Y Hao, Z Li… - Cancer research, 2006 - AACR
Malignant gliomas are highly lethal cancers dependent on angiogenesis. Critical tumor
subpopulations within gliomas share characteristics with neural stem cells. We examined …

Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents

G Minniti, R Muni, G Lanzetta, P Marchetti… - Anticancer …, 2009 - ar.iiarjournals.org
Glioblastoma is the most frequent and devastating primary malignant brain tumor in adults.
Surgery followed by standard radiotherapy with concomitant and adjuvant chemotherapy …

Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma

S Sathornsumetee, A Desjardins… - Neuro …, 2010 - academic.oup.com
Vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR)
signaling are established contributors to malignant glioma (MG) biology. We, therefore …

Current understanding on EGFR and Wnt/β-catenin signaling in glioma and their possible crosstalk

I Paul, S Bhattacharya, A Chatterjee… - Genes & …, 2013 - journals.sagepub.com
Glioblastoma multiformes (GBMs) are extensively heterogeneous at both cellular and
molecular levels. Current therapeutic strategies include targeting of key signaling molecules …

Lessons learned in the development of targeted therapy for malignant gliomas

AMP Omuro, S Faivre, E Raymond - Molecular cancer therapeutics, 2007 - AACR
The prognosis of patients with glioblastoma, anaplastic astrocytoma, and anaplastic
oligodendroglioma remains poor despite standard treatment with radiotherapy and …

A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma

DA Reardon, S Turner, KB Peters, A Desjardins… - Journal of the National …, 2011 - jnccn.org
Glioblastoma, the most common primary malignant brain tumor among adults, is a highly
angiogenic and deadly tumor. Angiogenesis in glioblastoma, driven by hypoxia-dependent …

Radiation resistance and stem-like cells in brain tumors

D Hambardzumyan, M Squartro, EC Holland - Cancer cell, 2006 - cell.com
The concepts of stem cells being resistant to therapy, stem-like cells existing in brain tumors,
and these tumors initially responding to therapy followed by recurrence are well …

In Vitro Drug Response and Efflux Transporters Associated with Drug Resistance in Pediatric High Grade Glioma and Diffuse Intrinsic Pontine Glioma

SJE Veringa, D Biesmans, DG van Vuurden… - PloS one, 2013 - journals.plos.org
Pediatric high-grade gliomas (pHGG), including diffuse intrinsic pontine gliomas (DIPG), are
the leading cause of cancer-related death in children. While it is clear that surgery (if …